Mark MacGregor

1.3k total citations
19 papers, 478 citations indexed

About

Mark MacGregor is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Mark MacGregor has authored 19 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Nephrology, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in Mark MacGregor's work include Dialysis and Renal Disease Management (11 papers), Chronic Kidney Disease and Diabetes (7 papers) and Blood Pressure and Hypertension Studies (4 papers). Mark MacGregor is often cited by papers focused on Dialysis and Renal Disease Management (11 papers), Chronic Kidney Disease and Diabetes (7 papers) and Blood Pressure and Hypertension Studies (4 papers). Mark MacGregor collaborates with scholars based in United Kingdom, Australia and United States. Mark MacGregor's co-authors include John Agar, Christopher R. Blagg, Nestor Velasco Bermeo, Andrew J. Innes, Shona Methven, Christopher J. Deighan, Mario Hair, Alan G. Jardine, R. S. C. Rodger and Maarten W. Taal and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied Physics Letters and Kidney International.

In The Last Decade

Mark MacGregor

19 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark MacGregor United Kingdom 11 261 111 80 69 52 19 478
Daniela Garzoni Switzerland 9 369 1.4× 122 1.1× 75 0.9× 39 0.6× 93 1.8× 13 588
Uttam Reddy United States 11 149 0.6× 105 0.9× 110 1.4× 95 1.4× 39 0.8× 36 530
Rezzan Ataman Türkiye 16 349 1.3× 171 1.5× 103 1.3× 122 1.8× 41 0.8× 39 732
K. Taub Canada 7 225 0.9× 80 0.7× 43 0.5× 131 1.9× 57 1.1× 10 489
Vincent Allot France 7 323 1.2× 80 0.7× 22 0.3× 70 1.0× 76 1.5× 12 552
Rita L. McGill United States 14 199 0.8× 110 1.0× 37 0.5× 193 2.8× 55 1.1× 49 450
Udaya Udayaraj United Kingdom 12 152 0.6× 111 1.0× 167 2.1× 77 1.1× 57 1.1× 25 419
Henk W. van Hamersvelt Netherlands 11 159 0.6× 45 0.4× 42 0.5× 24 0.3× 49 0.9× 28 404
Clémence Bechade France 13 485 1.9× 108 1.0× 39 0.5× 68 1.0× 60 1.2× 78 614
Edwin J. Macon United States 10 271 1.0× 114 1.0× 36 0.5× 76 1.1× 34 0.7× 12 457

Countries citing papers authored by Mark MacGregor

Since Specialization
Citations

This map shows the geographic impact of Mark MacGregor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark MacGregor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark MacGregor more than expected).

Fields of papers citing papers by Mark MacGregor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark MacGregor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark MacGregor. The network helps show where Mark MacGregor may publish in the future.

Co-authorship network of co-authors of Mark MacGregor

This figure shows the co-authorship network connecting the top 25 collaborators of Mark MacGregor. A scholar is included among the top collaborators of Mark MacGregor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark MacGregor. Mark MacGregor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Rutherford, Elaine, Sheila Ireland, Kenneth Mangion, et al.. (2020). A Randomized, Controlled Trial of the Effect of Allopurinol on Left Ventricular Mass Index in Hemodialysis Patients. Kidney International Reports. 6(1). 146–155. 11 indexed citations
2.
Prakash, Vineet, Adam Jacques, David Fluck, et al.. (2020). Sex differences in the agreement between left ventricular ejection fraction measured by myocardial perfusion scintigraphy and by echocardiography. SHILAP Revista de lepidopterología. 9. 405425345–405425345. 1 indexed citations
4.
So, Beng, Shona Methven, Mario Hair, Alan G. Jardine, & Mark MacGregor. (2015). Socio-economic status influences chronic kidney disease prevalence in primary care: a community-based cross-sectional analysis. Nephrology Dialysis Transplantation. 30(6). 1010–1017. 18 indexed citations
5.
Methven, Shona & Mark MacGregor. (2013). Empiricism or rationalism: how should we measure proteinuria?. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 50(4). 296–300. 9 indexed citations
6.
Munro, Carol A., Donna M. MacCallum, G. S. Shankland, et al.. (2012). Echinocandin resistance due to simultaneous FKS mutation and increased cell wall chitin in a Candida albicans bloodstream isolate following brief exposure to caspofungin. Journal of Medical Microbiology. 61(9). 1330–1334. 26 indexed citations
7.
MacGregor, Mark & Maarten W. Taal. (2011). Renal Association Clinical Practice Guideline on Detection, Monitoring and Management of Patients with CKD. Nephron Clinical Practice. 118(s1). c71–c100. 23 indexed citations
8.
Methven, Shona, Mark MacGregor, Jamie P. Traynor, et al.. (2010). Comparison of Urinary Albumin and Urinary Total Protein as Predictors of Patient Outcomes in CKD. American Journal of Kidney Diseases. 57(1). 21–28. 63 indexed citations
9.
Methven, Shona & Mark MacGregor. (2009). Clinical management of chronic kidney disease. Clinical Medicine. 9(3). 269–272. 2 indexed citations
10.
Agar, John, Mark MacGregor, & Christopher R. Blagg. (2007). Chronic maintenance hemodialysis: Making sense of the terminology. Hemodialysis International. 11(2). 252–262. 20 indexed citations
11.
MacGregor, Mark. (2007). Alternatives to standard hemodialysis. Hemodialysis International. 11(s2). 1 indexed citations
12.
MacGregor, Mark & Sue Carr. (2007). Hemodialysis in the United Kingdom. Hemodialysis International. 11(s2). 1 indexed citations
13.
MacGregor, Mark, John Agar, & Christopher R. Blagg. (2006). Home haemodialysis—international trends and variation. Nephrology Dialysis Transplantation. 21(7). 1934–1945. 70 indexed citations
14.
Bermeo, Nestor Velasco, et al.. (2006). Successful treatment of calciphylaxis with cinacalcet—an alternative to parathyroidectomy?. Nephrology Dialysis Transplantation. 21(7). 1999–2004. 86 indexed citations
15.
MacGregor, Mark, et al.. (2005). Factors Predicting Outcome in a Cohort of Patients With Atherosclerotic Renal Artery Disease Diagnosed by Magnetic Resonance Angiography. American Journal of Kidney Diseases. 46(6). 1065–1073. 8 indexed citations
16.
MacGregor, Mark, Christopher J. Deighan, R. S. C. Rodger, & J. M. Boulton‐Jones. (2005). A Prospective Open-Label Randomised Trial of Quinapril and/or Amlodipine in Progressive Non-Diabetic Renal Failure. Nephron Clinical Practice. 101(3). c139–c149. 14 indexed citations
17.
Griffin, Siân & Mark MacGregor. (2005). Facing an epidemic of chronic kidney disease. Clinical Medicine. 5(5). 521–525. 3 indexed citations
18.
Woo, Y Mun, Alan G. Jardine, A. F. Clark, et al.. (1999). Early graft function and patient survival following cadaveric renal transplantation. Kidney International. 55(2). 692–699. 87 indexed citations
19.
Ellis, Arthur B., Douglas Holmes, Mark MacGregor, et al.. (1988). Superconducting Bi-Ca-Sr-Cu oxide thin films by spray pyrolysis of metal acetates. Applied Physics Letters. 53(4). 324–326. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026